Clene Inc.
A clinical-stage biopharma developing nanotherapeutics for neurodegenerative diseases.
CLNN | US
Overview
Corporate Details
- ISIN(s):
- US1856341102 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 6550 SOUTH MILLROCK DRIVE, SUITE G50, 84121 SALT LAKE CITY
- Website:
- https://clene.com/
- Sector:
- Manufacturing
Description
Clene Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing nanotherapeutics to treat neurodegenerative diseases. The company's approach centers on its proprietary technology platform, which creates clean-surfaced, catalytically-active nanocrystals. These nanotherapeutics are designed to address cellular energy impairments, a key factor in the progression of many neurological conditions. By targeting these bioenergetic deficits, Clene aims to restore and protect neuronal health and function. The company is advancing a pipeline of drug candidates to address high unmet medical needs in diseases such as amyotrophic lateral sclerosis (ALS) and multiple sclerosis.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Clene Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Clene Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Clene Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
